Figure 2.
Effect of Bifidobacterium Infantis-mediated pTRKH2-PsT/sFlt-1 delivery system on HUVECs. 1: VEGF; 2: VEGF and treated fluid of the Bifidobacterium Infantis transformed with recombinant pTRKH2-PsT/sFlt-1 plasmid; 3: VEGF and treated fluid of the Bifidobacterium Infantis transformed with pTRKH2-PsT plasmid; 4: negative control. *P<0.05 vs VEGF group; #P<0.05 vs negative control.